Temporary COVID-19 Duty Remission Order Set to Expire on May 7, 2022

2022-04-21T16:05:27+00:00April 20th, 2022|Canada Customs, COVID-19, Other Government Agencies/Depts., Trade Compliance|

Will your goods be affected? CBSA Customs Notice 22-08 announced that the Certain Goods Remission Order (COVID-19): SOR/2020-101 will be repealed and entitlement to relief of customs duties for importers under the Order will end on May 7, 2022. Find out all the details here.

U.S. Now Requires COVID-19 Vaccination at Land Ports of Entry

2022-01-26T15:58:23+00:00January 26th, 2022|COVID-19, International Trade Issues, Logistics & Supply Chain Management|

Effective January 22, 2022, non-U.S. individuals seeking entry into the U.S. through land ports of entry and ferry terminals at the U.S.-Mexico and U.S.-Canada borders must be fully vaccinated for COVID-19 and provide related proof of vaccination. Details here.

APHIS Acceptance of Unoriginal Phytosanitary Docs Ending Dec. 31 (Updated)

2022-02-21T16:53:30+00:00December 16th, 2021|COVID-19, Other Government Agencies/Depts.|

A reminder that The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service will no longer be accepting unoriginal copies of phytosanitary certificates and forms after December 31, 2021. We detail everything you need to know of what types phytosanitary certificates are acceptable, processes and much more.

USITC Report Highlights COVID-19’s Impact on International Trade

2021-09-10T18:27:18+00:00September 9th, 2021|COVID-19, International Trade Issues, Other Government Agencies/Depts.|

The onset of the COVID-19 pandemic created a “unique global trade environment” in 2020 and left a a profound impact on global economic activities and international trade, the U.S. International Trade said in its annual trade overview published this week.

USTR Seeking Comments on Possible Extension of Sec. 301 Exclusions for Medical-Care Products

2021-08-30T17:13:53+00:00August 27th, 2021|COVID-19, U.S. Customs|

With COVID-19 cases in the U.S. on the rise again due to spread of the Delta variant, the administration seeking public input on whether to extend by up to another 6 months, the Section 301 exclusions for 99 COVID-19 response “medical-care products” that are currently set to expire on September 30, 2021.

Go to Top